We applied nicotine 21 mg and matching placebo transdermal patches to thirty haloperidol-treated patients with schizophrenia who smoked. Clinical assessments of bradykinesia-rigidity were lower during nicotine patch administration than during placebo patch administration.
|Original language||English (US)|
|Number of pages||3|
|State||Published - Oct 2002|
ASJC Scopus subject areas
- Psychiatry and Mental health